Covid-19 Vaccine

The JCVI recommended in January that children aged five to 11 years in a clinical risk group, or children who are a household contact of someone who is immunosuppressed, should be offered two doses of the Paediatric Pfizer-BioNTech COVID-19 vaccine with an interval of eight weeks between the first and second doses.